ETR:SRT - Sartorius Stock Price, News, & Analysis

Sartorius Aktiengesellschaft provides pharmaceutical and laboratory equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry. It provides filtration and purification, sterile filtration, virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, integrity testing, and OEM membranes; process analyzers, process control tools, microbiology products, and chemometric software; single-use bioprocess bags, containers, mixing systems, aseptic transfer systems, freeze and thaw systems, aseptic sampling and bottle closure systems, and tubing dis-/connectors; media USP and buffers DSP; bioreactors/fermentors; and FlexAct, a system that enables to custom-configure single-use solutions for entire biomanufacturing steps. The Lab Products & Services division provides laboratory instruments, such as lab balances, pipettes, and laboratory water purification systems; and consumables, including laboratory filters and pipette tips. Its products include OEM weigh cells, mass comparators and metrology, weights/weight sets, and paint mixing solutions; microbiology products and moisture analyzers; lab water systems; pipette tips and pipette calibration; bioreactors/fermentors and centrifuges; and filtration, ultrafiltration, membrane chromatography products, virus purification kits, diagnostic membranes and arrays, and blotting membranes, as well as aseptic bottle closure systems. The company also offers instrument, validation, and training services. It serves biopharmaceutical and pharmaceutical, public research institutes, and chemical and food sectors. The company was founded in 1870 and is headquartered in Goettingen, Germany.

Sartorius (ETR:SRT) Frequently Asked Questions

What is Sartorius' stock symbol?

Sartorius trades on the ETR under the ticker symbol "SRT."

What price target have analysts set for SRT?

8 equities research analysts have issued 12 month price objectives for Sartorius' stock. Their predictions range from €93.00 to €142.00. On average, they anticipate Sartorius' share price to reach €114.88 in the next year. This suggests that the stock has a possible downside of 12.6%. View Analyst Price Targets for Sartorius.

What is the consensus analysts' recommendation for Sartorius?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 4 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sartorius.

Has Sartorius been receiving favorable news coverage?

News coverage about SRT stock has been trending very negative on Thursday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sartorius earned a news sentiment score of -3.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of Sartorius' key competitors?

Some companies that are related to Sartorius include Carl Zeiss Meditec (AFX), NationalResearchCorp . (NRC), Senseonics (SENS), Senseonics (SENS), Integral Diagnostics (IDX), Akumin (AKU), Palatin Technologies (PTN), MaxCyte (MXCT), Profound Medical (PRN), Renalytix Ai (RENX), Yourgene Health (YGEN), Oncimmune (ONC), Lexagene (LXG), Sernova (SVA) and GeneNews (GEN).

What other stocks do shareholders of Sartorius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include United States Brent Oil Fund (BNO), Domino's Pizza (DPZ), American Eagle Outfitters (AEO), Gulfport Energy (GPOR), National Bank of Canada (NA), Velocity Data (VCT), Endologix (ELGX), Hyatt Hotels (H), Align Technology (ALGN) and AAR (AIR).

Who are Sartorius' key executives?

Sartorius' management team includes the folowing people:

• Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
• Mr. Rainer Lehmann, CFO & Member of Exec. Board (Age 43)
• Ms. Petra Kirchhoff, VP of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
• Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
• Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock price today?

One share of SRT stock can currently be purchased for approximately €131.50.

How big of a company is Sartorius?

Sartorius has a market capitalization of $8.99 billion and generates $1.57 billion in revenue each year.

What is Sartorius' official website?

The official website for Sartorius is http://www.sartorius.com.

How can I contact Sartorius?

The company can be reached via phone at 49 551 308 0.